Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-144,882
Closed -$2.24M 464
2023
Q3
$2.24M Sell
144,882
-21,414
-13% -$359K 0.07% 200
2023
Q2
$3.15M Sell
166,296
-31,145
-16% -$547K 0.14% 184
2023
Q1
$3.01M Buy
197,441
+85,841
+77% +$1.12M 0.13% 196
2022
Q4
$1.42M Buy
111,600
+2,000
+2% +$18K 0.07% 349
2022
Q3
$635K Buy
+109,600
New +$482K 0.02% 476

Other funds holding ETNB

Picton Mahoney Asset Management's ETNB Position: Q4 2023 in Review

Picton Mahoney Asset Management sold out of 89bio (ETNB) in Q4 2023, closing a stake of 144,882 shares — an estimated $2.24M sold.

Picton Mahoney Asset Management first reported a position in ETNB in Q3 2022 and held it in 5 quarters. The position peaked at $3.15M in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Picton Mahoney Asset Management reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 144,882 89bio shares in Q4 2023, an estimated $2.24M.
  • Picton Mahoney Asset Management first reported a position in 89bio in Q3 2022 and held it in 5 quarters.
  • Picton Mahoney Asset Management's 89bio position peaked at $3.15M in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.